The objective of this study was to assess the effect of @entity3303 jelly application to chest tubes on the intensity and duration of @entity158 , chest tube site @entity158 and the required analgesics for @entity282 relief in coronary artery bypass graft (CABG) @entity1 . For @entity1 in group L, we applied sterile 2% @entity3303 jelly on the chest tubes just before insertion, and for @entity1 in group C, we applied normal saline. Overall visual analogue scale (VAS), maximal @entity158 area with their VAS were documented postoperatively, and the frequency that button of @entity1 -controlled analgesia was pressed (FPB) and total @entity3575 consumption were assessed. The number of @entity1 who complained that tube site was the most @entity158 site was significantly higher in group C than in group L (85% vs. 30% at extubation, P<0.001). The overall VAS score was significantly higher in group C than in group L (39.14  12.49 vs. 27.74  13.76 at extubation, P=0.006). After all of the tubes were removed, the VAS score decreased more in group C (5.74  4.77, P<0.001) than in group L (3.05  2.48, P<0.001). FPB and total @entity3575 consumption were significantly higher in group C than in group L (73.00, 59.00-78.00 vs. 34.00, 31.00-39.25, P<0.001; 2,214.65  37.01 vs. 1,720.19  361.63, P<0.001, respectively). @entity3303 jelly application is a very simple way to reduce @entity282 by reducing chest tube site @entity158 after CABG. (Clinical Trials Registry No. ACTRN 12611001215910).

Application of XXXX jelly on chest tubes to reduce @entity158 caused by drainage catheter after coronary artery bypass surgery.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity3303 :: ('MESH:D008012', 'Chemical') :: ['Lidocaine', 'lidocaine'] @entity158 :: ('MESH:D010146', 'Disease') :: ['overall pain', 'pain', 'painful'] @entity282 :: ('MESH:D010149', 'Disease') :: ['postoperative pain'] @entity3575 :: ('MESH:D005283', 'Chemical') :: ['fentanyl']
@entity3303 :: (MESH:D008012,Chemical) :: ['lidocaine']
